Challenges in the development of an M 4 PAM preclinical candidate: The discovery, SAR, and in vivo characterization of a series of 3-aminoazetidine-derived amides.

MLA

Tarr, James C., et al. “Challenges in the Development of an M 4 PAM Preclinical Candidate: The Discovery, SAR, and in Vivo Characterization of a Series of 3-Aminoazetidine-Derived Amides.” Bioorganic & Medicinal Chemistry Letters, vol. 27, no. 13, July 2017, pp. 2990–95. EBSCOhost, https://doi.org/10.1016/j.bmcl.2017.05.014.

APA

Tarr, J. C., Wood, M. R., Noetzel, M. J., Bertron, J. L., Weiner, R. L., Rodriguez, A. L., Lamsal, A., Byers, F. W., Chang, S., Cho, H. P., Jones, C. K., Niswender, C. M., Wood, M. W., Brandon, N. J., Duggan, M. E., Conn, P. J., Bridges, T. M., & Lindsley, C. W. (2017). Challenges in the development of an M 4 PAM preclinical candidate: The discovery, SAR, and in vivo characterization of a series of 3-aminoazetidine-derived amides. Bioorganic & Medicinal Chemistry Letters, 27(13), 2990–2995. https://doi.org/10.1016/j.bmcl.2017.05.014

Chicago

Tarr, James C, Michael R Wood, Meredith J Noetzel, Jeanette L Bertron, Rebecca L Weiner, Alice L Rodriguez, Atin Lamsal, et al. 2017. “Challenges in the Development of an M 4 PAM Preclinical Candidate: The Discovery, SAR, and in Vivo Characterization of a Series of 3-Aminoazetidine-Derived Amides.” Bioorganic & Medicinal Chemistry Letters 27 (13): 2990–95. doi:10.1016/j.bmcl.2017.05.014.